BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23487813)

  • 1. Diffuse multiple sclerosis and chronic central serous chorioretinopathy: pitfall not to ignore.
    Milazzo S; Drimbea A; Betermiez P; Al Fayez S; Bremond-Gignac D
    Pract Neurol; 2013 Jun; 13(3):200-3. PubMed ID: 23487813
    [No Abstract]   [Full Text] [Related]  

  • 2. Leopard-Spot Subretinal Deposits in Central Serous Chorioretinopathy.
    Marchese A; Miserocchi E; Modorati G; Querques G; Bandello F
    Retina; 2018 Jul; 38(7):e53-e54. PubMed ID: 29697592
    [No Abstract]   [Full Text] [Related]  

  • 3. Central serous chorioretinopathy in myopic patients.
    Yzer S; Fung AT; Barbazetto I; Yannuzzi LA; Freund KB
    Arch Ophthalmol; 2012 Oct; 130(10):1339-40. PubMed ID: 23044956
    [No Abstract]   [Full Text] [Related]  

  • 4. Retinal microstructural abnormalities in central serous chorioretinopathy and polypoidal choroidal vasculopathy.
    Ooto S; Tsujikawa A; Mori S; Tamura H; Yamashiro K; Otani A; Yoshimura N
    Retina; 2011 Mar; 31(3):527-34. PubMed ID: 20890237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
    Song IS; Shin YU; Lee BR
    Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of three-dimensional optical coherence tomography and fundus photochromy in correlating the fluorescein leaking sites of acute central serous chorioretinopathy.
    Wang GH; Zhang J; Zhang D; Lv FL; Wang LX
    Med Princ Pract; 2011; 20(3):283-6. PubMed ID: 21455001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of central serous chorioretinopathy: Expert panel discussion.
    Chhablani J; Anantharaman G; Behar-Cohen F; Boon C; Manayath G; Singh R
    Indian J Ophthalmol; 2018 Dec; 66(12):1700-1703. PubMed ID: 30451169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Therapeutic Challenges.
    La Spina C; Modorati GM; Bandello F; Querques G; Roberts P; Fawzi AA
    Retina; 2018 Feb; 38(2):432-437. PubMed ID: 28272282
    [No Abstract]   [Full Text] [Related]  

  • 9. Central serous chorioretinopathy after surgical repair of a blowout fracture.
    Chang M; Baek S; Lee TS
    J Craniofac Surg; 2012 Nov; 23(6):1923-4. PubMed ID: 23172445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic findings in acute central serous chorioretinopathy using spectral domain-optical coherence tomography with simultaneous angiography.
    Shinojima A; Hirose T; Mori R; Kawamura A; Yuzawa M
    Retina; 2010 Feb; 30(2):193-202. PubMed ID: 20142712
    [No Abstract]   [Full Text] [Related]  

  • 11. Spectral domain optical coherence tomography and angiographic findings in central serous chorioretinopathy complicated by bilateral nonrhegmatogenous retinal detachment associated with systemic corticosteroids.
    Arantes TE; Garcia CR; Rossi MR; Muccioli C
    Ocul Immunol Inflamm; 2009; 17(5):316-8. PubMed ID: 19831561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the OCT Spectrum of Acute Central Serous Chorioretinopathy: The Stalagmite-Stalactite Pattern.
    Ramtohul P; Comet A; Denis D
    Ophthalmol Retina; 2019 Aug; 3(8):636. PubMed ID: 31383396
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute vision loss in multiple sclerosis: Optic neuritis or central serous chorioretinopathy?
    Abtahi MA; Dehghani A; Etemadifar M; Mahmoudi F; Akbari M; Rodriguez M; Fereidan-Esfahani M; Jahanbani-Ardakani H; Abtahi SH
    Mult Scler Relat Disord; 2019 Jan; 27():147-150. PubMed ID: 30384200
    [No Abstract]   [Full Text] [Related]  

  • 14. Macular pigment optical density in central serous chorioretinopathy.
    Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Hamasaki T
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5219-25. PubMed ID: 20445108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy.
    Matsumoto H; Kishi S; Sato T; Mukai R
    Am J Ophthalmol; 2011 Apr; 151(4):617-623.e1. PubMed ID: 21257153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.
    Maruko I; Iida T; Ojima A; Sekiryu T
    Retina; 2011 Apr; 31(4):759-65. PubMed ID: 21052035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic challenges.
    Wong IY; Lam JK; Cebulla CM
    Retina; 2013 May; 33(5):1076-80. PubMed ID: 23296050
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective retina therapy for acute central serous chorioretinopathy.
    Klatt C; Saeger M; Oppermann T; Pörksen E; Treumer F; Hillenkamp J; Fritzer E; Brinkmann R; Birngruber R; Roider J
    Br J Ophthalmol; 2011 Jan; 95(1):83-8. PubMed ID: 20554506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of acute vision loss: central serous chorioretinopathy.
    Pare JR; Guo Y; Schechter-Perkins EM
    Am J Emerg Med; 2014 Apr; 32(4):396.e3-4. PubMed ID: 24342864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic differences, according to etiology, in pigment epithelial detachments by means of en face optical coherence tomography.
    Lumbroso B; Savastano MC; Rispoli M; Balestrazzi A; Savastano A; Balestrazzi E
    Retina; 2011 Mar; 31(3):553-8. PubMed ID: 21343873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.